Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,067,988
in 15 filings, $36.6M under 10b5-1 plans

Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MAHONEY DAVID L −$12.3M Director sold 8% of stake
  2. Maduck Sean −$11.7M See Remarks sold 91% of stake
  3. Vieira Roberto Wandenkolk −$8.1M President, Oncology sold 95% of stake
  4. Park Kimberly −$3.3M Director sold 100% of stake
  5. Lyon Joseph Douglas −$2.3M See Remarks sold 78% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-02 Lyon Joseph Douglas See Remarks Grant or award +398 $35.97 $14K 10,921
2026-03-02 Lyon Joseph Douglas See Remarks Grant or award +398 11,319
2026-03-02 Maduck Sean See Remarks Grant or award +454 $35.97 $16K 8,633
2026-03-02 Maduck Sean See Remarks Grant or award +454 9,087
2026-03-02 Robb Gary Charles Chief Business Officer Grant or award +499 $35.97 $18K 79,125
2026-03-02 Robb Gary Charles Chief Business Officer Grant or award +499 79,624
2026-03-02 Guyer William Chief Development Officer Grant or award +498 $35.97 $18K 1,733
2026-03-02 Guyer William Chief Development Officer Grant or award +498 2,231
2026-03-02 Mokari Atabak Chief Financial Officer Grant or award +397 $35.97 $14K 14,956
2026-03-02 Mokari Atabak Chief Financial Officer Grant or award +397 15,353
2026-02-27 Lyon Joseph Douglas See Remarks Grant or award · Stock Option (right to buy) +140,000 140,000
2026-02-27 BELANOFF JOSEPH K Chief Executive Officer Grant or award · Stock Option (right to buy) +460,000 460,000
2026-02-27 Mokari Atabak Chief Financial Officer Grant or award · Stock Option (right to buy) +140,000 140,000
2026-02-27 Maduck Sean See Remarks Grant or award · Stock Option (right to buy) +140,000 140,000
2026-02-27 Hunt Hazel Chief Scientific Officer Grant or award · Stock Option (right to buy) +140,000 140,000
2026-02-27 Robb Gary Charles Chief Business Officer Grant or award · Stock Option (right to buy) +140,000 140,000
2026-02-27 Guyer William Chief Development Officer Grant or award · Stock Option (right to buy) +140,000 140,000
2026-02-24 WILSON JAMES N Director Option exercise +100,000 $3.88 $388K 100,000
2026-02-24 WILSON JAMES N Director Shares withheld for taxes −10,636 $36.48 $388K 89,364
2026-02-24 WILSON JAMES N Director Gift −89,364 0

Page 13 of 61 · 1,220 trades